The U.S. Food and Drug Administration is working with Deerfield, Ill.-based Baxter Healthcare, Evanston, Ill.-based B. Braun Medical and Lake Forest, Ill.-based Hospira to address the issue, according to the news release.
More Articles on the FDA:
FDA Bans Ranbaxy Laboratories From Manufacturing, Importing Drugs
FDA Drug Approval Processes Not Consistent
FDA Appoints Dr. Rafael Miguel to Anesthetic and Analgesic Drug Products Advisory Committee
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
